Nobilis Health Corp (NRTSF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 8,166 | 4,346 | 1,242 | 1,190 | -10,260 |
| Depreciation Amortization | 1,034 | 664 | 330 | 730 | 0 |
| Accounts receivable | -4,054 | -1,464 | 1,527 | N/A | 0 |
| Other Working Capital | -4,298 | -2,227 | 1,058 | -2,110 | N/A |
| Other Operating Activity | 3,675 | 845 | -1,958 | 3,670 | 53,210 |
| Operating Cash Flow | $4,523 | $2,164 | $2,199 | $3,480 | $42,950 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,643 | -1,124 | -581 | -1,170 | 0 |
| Net Acquisitions | N/A | N/A | N/A | -460 | 0 |
| Purchase Of Investment | -150 | -150 | -150 | N/A | N/A |
| Other Investing Activity | 484 | -116 | -346 | -310 | -11,960 |
| Investing Cash Flow | $-1,309 | $-1,390 | $-1,077 | $-1,940 | $-11,960 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -361 | -58 | -11 | N/A | 0 |
| Common Stock Issued | 3,124 | 28 | 28 | N/A | 0 |
| Other Financing Activity | 1,905 | -2,158 | -803 | -160 | -105,660 |
| Financing Cash Flow | $4,668 | $-2,188 | $-786 | $-160 | $-105,660 |
| Exchange Rate Effect | -195 | N/A | N/A | 0 | 70 |
| Beginning Cash Position | 5,602 | 5,602 | 5,602 | 4,220 | 629,840 |
| End Cash Position | 13,289 | 4,188 | 5,938 | 5,600 | 555,240 |
| Net Cash Flow | $7,687 | $-1,414 | $336 | $1,380 | $-74,600 |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,523 | 2,164 | 2,199 | 3,480 | 42,950 |
| Capital Expenditure | -1,682 | -1,124 | -581 | N/A | 0 |
| Free Cash Flow | 2,841 | 1,040 | 1,618 | 3,480 | 42,950 |